Stocksigma LogoStocksigma Logo

NephroPlus Reports Strong H1FY27 Performance and International Expansion

Nephrocare Health Services delivered strong H1FY27 results, with revenue growing 23.6% YoY to ₹585.2 crore, driven by a 12.6% YoY rise in treatments to

NephroPlus Reports Strong H1FY27 Performance and International Expansion

Nephrocare Health Services Ltd · Investor Presentation · 03 Nov 2026, 11:57 pm

NephroPlus Reports Strong H1FY27 Performance and International Expansion Nephrocare Health Services delivered strong H1FY27 results, with revenue growing 23.6% YoY to ₹585.2 crore, driven by a 12.6% YoY rise in treatments to 21.01 lakh and a 9.7% YoY increase in revenue per treatment to ₹2,785. Adjusted EBITDA rose 15.3% YoY to ₹134.4 crore (23.0% margin), while adjusted PAT surged 34.7% YoY to ₹76.1 crore. The global clinic network expanded to 570 centres across six countries, with international operations contributing 47% of Q2FY27 revenue following entries into Kazakhstan and Saudi Arabia alongside Philippines expansion.

Original exchange filing (PDF)

More announcements from Nephrocare Health Services Ltd

All Nephrocare Health Services Ltd announcements